Staar Surgical (NSDQ:STAA) shares ticked up today on second-quarter results that topped the consensus forecast.
The Lake Forest, Calif.-based implantable lens maker posted profits of $8.6 million, or 17¢ per share, on sales of $62.4 million for the three months ended July 2, 2021, for a massive bottom-line from over $1 million in the red this time last year on sales growth of 77.2%.
Adjusted to exclude one-time items, earnings per share were 27¢, 3¢ ahead of Wall Street, where analysts were looking for sales of $52.6 million.
“STAAR’s second-quarter results reflect the accelerating sales momentum and significant opportunity for our vision correction lenses,” Staar Surgical president & CEO Caren Mason said in a news release. “Global ICL unit growth increased 79% over the prior-year quarter and we achieved positive sales and unit growth in all of our major markets. Asia, Europe, and the U.S. led our outperformance during the quarter. The Mi…